| 000 | 01539 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513050129.0 | ||
| 264 | 0 | _c19950330 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Rhee, F | |
| 245 | 0 | 0 |
_aQuantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow. _h[electronic resource] |
| 260 |
_bLeukemia _cFeb 1995 |
||
| 300 |
_a329-35 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aBlood Cells _xpathology |
| 650 | 0 | 4 |
_aBone Marrow _xpathology |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xpathology |
| 650 | 0 | 4 | _aPhiladelphia Chromosome |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xblood |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-abl _xanalysis |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 |
_aRNA, Neoplasm _xanalysis |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 700 | 1 | _aMarks, D I | |
| 700 | 1 | _aLin, F | |
| 700 | 1 | _aSzydlo, R M | |
| 700 | 1 | _aHochhaus, A | |
| 700 | 1 | _aTreleaven, J | |
| 700 | 1 | _aDelord, C | |
| 700 | 1 | _aCross, N C | |
| 700 | 1 | _aGoldman, J M | |
| 773 | 0 |
_tLeukemia _gvol. 9 _gno. 2 _gp. 329-35 |
|
| 999 |
_c7869108 _d7869108 |
||